Related Experiment Video
Updated: May 9, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
Nuclear export mediated regulation of microRNAs: potential target for drug intervention
Irfana Muqbil1, Bin Bao, Abdul Badi Abou-Samra
1Department of Biochemistry Faculty of Life Sciences, AMU Aligarh, 202002 UP, India.
Abstract:
MicroRNAs (miRNAs) are short non-coding RNAs that have been recognized to regulate the expression of uncountable number of genes. Their aberrant expression has been found to be linked to the pathology of many diseases including cancer. There is a drive to develop miRNA targeted therapeutics for different diseases especially cancer. Nevertheless, reining in these short non-coding RNAs is not as straightforward as originally thought. This is in view of the recent discoveries that miRNAs are under epigenetic regulations at multiple levels. Exportin 5 protein (XPO5) nuclear export mediated regulation of miRNAs is one such important epigenetic mechanism. XPO5 is responsible for exporting precursor miRNAs through the nuclear membrane to the cytoplasm, and is thus a critical step in miRNA biogenesis. A number of studies have shown that variations in components of the miRNA biogenesis pathways, particularly the aberrant expression of XPO5, increase the risk of developing cancer. In addition to XPO5, the Exportin 1 protein (XPO1) or chromosome region maintenance 1 (CRM1) can also carry miRNA export function. These findings are supported by pathway analyses that reveal certain miRNAs as direct interaction partners of CRM1. An in depth understanding of miRNA export mediated regulatory mechanisms is important for the successful design of clinically viable therapeutics. In this review, we describe the current knowledge on the mechanisms of miRNA nuclear transport mediated regulation and propose strategies to selectively block this important mechanism in cancer.
Insights
Exportin 5 (XPO5) and Exportin 1 (XPO1) regulate microRNA (miRNA) nuclear export, a critical step in miRNA biogenesis. Understanding these epigenetic mechanisms is key for developing targeted cancer therapeutics.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- MicroRNAs (miRNAs) are key gene regulators implicated in various diseases, including cancer.
- Aberrant miRNA expression and epigenetic dysregulation are increasingly recognized in disease pathology.
- Targeting miRNAs for therapeutic development faces challenges due to complex regulatory networks.
Purpose of the Study:
- To review the epigenetic regulation of miRNA nuclear export.
- To elucidate the roles of Exportin 5 (XPO5) and Exportin 1 (XPO1) in miRNA biogenesis and cancer.
- To propose strategies for blocking miRNA export in cancer therapy.
Main Methods:
- Literature review of miRNA biogenesis and nuclear transport mechanisms.
- Analysis of studies linking XPO5 and XPO1 to miRNA export and cancer risk.
- Pathway analysis of miRNA interactions with CRM1 (XPO1).
Main Results:
- XPO5 mediates the nuclear export of precursor miRNAs, a crucial step in their maturation.
- Aberrant XPO5 expression is associated with increased cancer risk.
- XPO1 (CRM1) also participates in miRNA export, with direct miRNA interaction partners identified.
Conclusions:
- MiRNA nuclear export, regulated by XPO5 and XPO1, is a critical epigenetic mechanism.
- Dysregulation of miRNA export pathways contributes to cancer development.
- Targeting miRNA export offers a potential strategy for novel cancer therapeutics.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Regulation of Nuclear Protein Sorting
Nuclear Export of mRNA

